ARTICLE SUMMARY:
The Irish-American company is carefully rolling out its BioHealx technology for the treatment of anal fistulas as it works with surgeons to standardize and optimize the procedure.
Signum Surgical’s chief technology officer Eoin Bambury and chief innovation officer Moshe Zilversmit founded the company in 2016 following their experience as fellows in the University of Galway’s BioInnovate program.
